# AET04_PI full table is produced correctly

    Code
      res
    Output
                                                                                   Placebo                                Xanomeline High Dose                           Xanomeline Low Dose            
                                                                 Any Grade (%)   Grade 3-4 (%)   Grade 5 (%)   Any Grade (%)   Grade 3-4 (%)   Grade 5 (%)   Any Grade (%)   Grade 3-4 (%)   Grade 5 (%)
                                                                    (N=86)          (N=86)         (N=86)         (N=72)          (N=72)         (N=72)         (N=96)          (N=96)         (N=96)   
      ——————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
      SKIN AND SUBCUTANEOUS TISSUE DISORDERS                                                                                                                                                            
      Total number of patients with at least one adverse event    19 (22.1%)       4 (4.7%)           0         34 (47.2%)       6 (8.3%)           0         35 (36.5%)       6 (6.2%)       2 (2.1%)  
        PRURITUS                                                       9               3              0             36               8              0             24               1              1     
        ERYTHEMA                                                      10               0              0             19               0              0             16               2              0     
        RASH                                                           6               1              0             15               1              0             14               2              0     
        SKIN IRRITATION                                                3               0              0              7               0              0              6               1              1     
      GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS                                                                                                                                              
      Total number of patients with at least one adverse event    15 (17.4%)       3 (3.5%)           0         30 (41.7%)       6 (8.3%)           0         35 (36.5%)       9 (9.4%)           0     
        APPLICATION SITE PRURITUS                                      7               2              0             29               3              0             24               3              0     
        APPLICATION SITE ERYTHEMA                                      3               0              0             19               3              0             14               2              0     
        APPLICATION SITE DERMATITIS                                    6               1              0             10               1              0              9               1              0     
        APPLICATION SITE IRRITATION                                    3               1              0             12               1              0              9               3              0     
      NERVOUS SYSTEM DISORDERS                                                                                                                                                                          
      Total number of patients with at least one adverse event     8 (9.3%)        1 (1.2%)           0         15 (20.8%)       2 (2.8%)           0         10 (10.4%)       1 (1.0%)           0     
        DIZZINESS                                                      2               0              0             15               3              0              9               1              0     
        HEADACHE                                                       8               1              0              8               0              0              3               0              0     
      GASTROINTESTINAL DISORDERS                                                                                                                                                                        
      Total number of patients with at least one adverse event    12 (14.0%)       1 (1.2%)           0          9 (12.5%)       2 (2.8%)       1 (1.4%)       9 (9.4%)        3 (3.1%)           0     
        DIARRHOEA                                                     10               1              0              4               0              0              6               2              0     
        NAUSEA                                                         3               0              0              8               3              1              3               1              0     
      CARDIAC DISORDERS                                                                                                                                                                                 
      Total number of patients with at least one adverse event     2 (2.3%)            0              0          8 (11.1%)           0              0          7 (7.3%)            0              0     
        SINUS BRADYCARDIA                                              2               0              0             11               0              0              7               0              0     
      INFECTIONS AND INFESTATIONS                                                                                                                                                                       
      Total number of patients with at least one adverse event     2 (2.3%)            0              0          6 (8.3%)        1 (1.4%)           0          4 (4.2%)        1 (1.0%)           0     
        NASOPHARYNGITIS                                                2               0              0              8               1              0              4               1              0     
      VASCULAR DISORDERS                                                                                                                                                                                
      Total number of patients with at least one adverse event         0               0              0          1 (1.4%)            0              0              0               0              0     
        WOUND HAEMORRHAGE                                              0               0              0              1               0              0              0               0              0     

# AET04_PI variant 1 is produced correctly

    Code
      res
    Output
                                                                               Placebo                                Xanomeline High Dose                           Xanomeline Low Dose            
                                                             Any Grade (%)   Grade 3-4 (%)   Grade 5 (%)   Any Grade (%)   Grade 3-4 (%)   Grade 5 (%)   Any Grade (%)   Grade 3-4 (%)   Grade 5 (%)
                                                                (N=86)          (N=86)         (N=86)         (N=72)          (N=72)         (N=72)         (N=96)          (N=96)         (N=96)   
      ——————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
      SKIN AND SUBCUTANEOUS TISSUE DISORDERS                                                                                                                                                        
      PRURITUS                                                     9               3              0             36               8              0             24               1              1     
      ERYTHEMA                                                    10               0              0             19               0              0             16               2              0     
      RASH                                                         6               1              0             15               1              0             14               2              0     
      SKIN IRRITATION                                              3               0              0              7               0              0              6               1              1     
      GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS                                                                                                                                          
      APPLICATION SITE PRURITUS                                    7               2              0             29               3              0             24               3              0     
      APPLICATION SITE ERYTHEMA                                    3               0              0             19               3              0             14               2              0     
      APPLICATION SITE DERMATITIS                                  6               1              0             10               1              0              9               1              0     
      APPLICATION SITE IRRITATION                                  3               1              0             12               1              0              9               3              0     
      NERVOUS SYSTEM DISORDERS                                                                                                                                                                      
      DIZZINESS                                                    2               0              0             15               3              0              9               1              0     
      HEADACHE                                                     8               1              0              8               0              0              3               0              0     
      GASTROINTESTINAL DISORDERS                                                                                                                                                                    
      DIARRHOEA                                                   10               1              0              4               0              0              6               2              0     
      NAUSEA                                                       3               0              0              8               3              1              3               1              0     
      CARDIAC DISORDERS                                                                                                                                                                             
      SINUS BRADYCARDIA                                            2               0              0             11               0              0              7               0              0     
      INFECTIONS AND INFESTATIONS                                                                                                                                                                   
      NASOPHARYNGITIS                                              2               0              0              8               1              0              4               1              0     

# AET04_PI variant 2 is produced correctly

    Code
      res
    Output
                                                                 Placebo                                Xanomeline High Dose                           Xanomeline Low Dose            
                                               Any Grade (%)   Grade 3-4 (%)   Grade 5 (%)   Any Grade (%)   Grade 3-4 (%)   Grade 5 (%)   Any Grade (%)   Grade 3-4 (%)   Grade 5 (%)
                                                  (N=86)          (N=86)         (N=86)         (N=72)          (N=72)         (N=72)         (N=96)          (N=96)         (N=96)   
      ————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
      SKIN AND SUBCUTANEOUS TISSUE DISORDERS                                                                                                                                          
      PRURITUS                                       9               3              0             36               8              0             24               1              1     
      ERYTHEMA                                      10               0              0             19               0              0             16               2              0     
      NERVOUS SYSTEM DISORDERS                                                                                                                                                        
      HEADACHE                                       8               1              0              8               0              0              3               0              0     
      GASTROINTESTINAL DISORDERS                                                                                                                                                      
      DIARRHOEA                                     10               1              0              4               0              0              6               2              0     

# AET04_PI variant 3 is produced correctly

    Code
      res
    Output
                                                                               Placebo                                Xanomeline High Dose                           Xanomeline Low Dose            
                                                             Any Grade (%)   Grade 3-4 (%)   Grade 5 (%)   Any Grade (%)   Grade 3-4 (%)   Grade 5 (%)   Any Grade (%)   Grade 3-4 (%)   Grade 5 (%)
                                                                (N=86)          (N=86)         (N=86)         (N=72)          (N=72)         (N=72)         (N=96)          (N=96)         (N=96)   
      ——————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
      SKIN AND SUBCUTANEOUS TISSUE DISORDERS                                                                                                                                                        
      PRURITUS                                                     9               3              0             36               8              0             24               1              1     
      ERYTHEMA                                                    10               0              0             19               0              0             16               2              0     
      RASH                                                         6               1              0             15               1              0             14               2              0     
      GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS                                                                                                                                          
      APPLICATION SITE PRURITUS                                    7               2              0             29               3              0             24               3              0     
      APPLICATION SITE ERYTHEMA                                    3               0              0             19               3              0             14               2              0     
      APPLICATION SITE IRRITATION                                  3               1              0             12               1              0              9               3              0     
      NERVOUS SYSTEM DISORDERS                                                                                                                                                                      
      DIZZINESS                                                    2               0              0             15               3              0              9               1              0     
      GASTROINTESTINAL DISORDERS                                                                                                                                                                    
      DIARRHOEA                                                   10               1              0              4               0              0              6               2              0     
      CARDIAC DISORDERS                                                                                                                                                                             
      SINUS BRADYCARDIA                                            2               0              0             11               0              0              7               0              0     

# AET04_PI variant 4 is produced correctly

    Code
      res
    Output
                                                                 Placebo                                Xanomeline High Dose                           Xanomeline Low Dose            
                                               Any Grade (%)   Grade 3-4 (%)   Grade 5 (%)   Any Grade (%)   Grade 3-4 (%)   Grade 5 (%)   Any Grade (%)   Grade 3-4 (%)   Grade 5 (%)
                                                  (N=86)          (N=86)         (N=86)         (N=72)          (N=72)         (N=72)         (N=96)          (N=96)         (N=96)   
      ————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
      SKIN AND SUBCUTANEOUS TISSUE DISORDERS                                                                                                                                          
      PRURITUS                                       9               3              0             36               8              0             24               1              1     

# AET04_PI variant 5 is produced correctly

    Code
      res
    Output
                                                                               Placebo                                Xanomeline High Dose                           Xanomeline Low Dose            
                                                             Any Grade (%)   Grade 3-4 (%)   Grade 5 (%)   Any Grade (%)   Grade 3-4 (%)   Grade 5 (%)   Any Grade (%)   Grade 3-4 (%)   Grade 5 (%)
                                                                (N=86)          (N=86)         (N=86)         (N=72)          (N=72)         (N=72)         (N=96)          (N=96)         (N=96)   
      ——————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
      SKIN AND SUBCUTANEOUS TISSUE DISORDERS                                                                                                                                                        
      PRURITUS                                                     9               3              0             36               8              0             24               1              1     
      ERYTHEMA                                                    10               0              0             19               0              0             16               2              0     
      RASH                                                         6               1              0             15               1              0             14               2              0     
      SKIN IRRITATION                                              3               0              0              7               0              0              6               1              1     
      GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS                                                                                                                                          
      APPLICATION SITE PRURITUS                                    7               2              0             29               3              0             24               3              0     
      APPLICATION SITE ERYTHEMA                                    3               0              0             19               3              0             14               2              0     
      APPLICATION SITE IRRITATION                                  3               1              0             12               1              0              9               3              0     
      NERVOUS SYSTEM DISORDERS                                                                                                                                                                      
      DIZZINESS                                                    2               0              0             15               3              0              9               1              0     
      GASTROINTESTINAL DISORDERS                                                                                                                                                                    
      DIARRHOEA                                                   10               1              0              4               0              0              6               2              0     
      NAUSEA                                                       3               0              0              8               3              1              3               1              0     
      CARDIAC DISORDERS                                                                                                                                                                             
      SINUS BRADYCARDIA                                            2               0              0             11               0              0              7               0              0     

# AET04_PI variant 6 is produced correctly

    Code
      res
    Output
                                                                                       Placebo                                                Xanomeline High Dose                                           Xanomeline Low Dose                    
                                                             Any Grade (%)   Grade 1-2 (%)   Grade 3-4 (%)   Grade 5 (%)   Any Grade (%)   Grade 1-2 (%)   Grade 3-4 (%)   Grade 5 (%)   Any Grade (%)   Grade 1-2 (%)   Grade 3-4 (%)   Grade 5 (%)
                                                                (N=86)          (N=86)          (N=86)         (N=86)         (N=72)          (N=72)          (N=72)         (N=72)         (N=96)          (N=96)          (N=96)         (N=96)   
      ——————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
      SKIN AND SUBCUTANEOUS TISSUE DISORDERS                                                                                                                                                                                                        
      PRURITUS                                                     9               6               3              0             36              28               8              0             24              22               1              1     
      ERYTHEMA                                                    10              10               0              0             19              19               0              0             16              14               2              0     
      RASH                                                         6               5               1              0             15              14               1              0             14              11               2              0     
      GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS                                                                                                                                                                                          
      APPLICATION SITE PRURITUS                                    7               5               2              0             29              26               3              0             24              21               3              0     
      APPLICATION SITE ERYTHEMA                                    3               3               0              0             19              17               3              0             14              11               2              0     
      APPLICATION SITE IRRITATION                                  3               2               1              0             12              11               1              0              9               6               3              0     
      NERVOUS SYSTEM DISORDERS                                                                                                                                                                                                                      
      DIZZINESS                                                    2               2               0              0             15              12               3              0              9               8               1              0     
      GASTROINTESTINAL DISORDERS                                                                                                                                                                                                                    
      DIARRHOEA                                                   10               9               1              0              4               4               0              0              6               4               2              0     
      CARDIAC DISORDERS                                                                                                                                                                                                                             
      SINUS BRADYCARDIA                                            2               2               0              0             11              11               0              0              7               7               0              0     

# AET04_PI variant 7 is produced correctly

    Code
      res
    Output
                                                                                       Placebo                                                Xanomeline High Dose                                           Xanomeline Low Dose                    
                                                             Any Grade (%)   Grade 3-4 (%)   Grade 3-5 (%)   Grade 5 (%)   Any Grade (%)   Grade 3-4 (%)   Grade 3-5 (%)   Grade 5 (%)   Any Grade (%)   Grade 3-4 (%)   Grade 3-5 (%)   Grade 5 (%)
                                                                (N=86)          (N=86)          (N=86)         (N=86)         (N=72)          (N=72)          (N=72)         (N=72)         (N=96)          (N=96)          (N=96)         (N=96)   
      ——————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
      SKIN AND SUBCUTANEOUS TISSUE DISORDERS                                                                                                                                                                                                        
      PRURITUS                                                     9               3               3              0             36               8               8              0             24               1               2              1     
      ERYTHEMA                                                    10               0               0              0             19               0               0              0             16               2               2              0     
      RASH                                                         6               1               1              0             15               1               1              0             14               2               2              0     
      GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS                                                                                                                                                                                          
      APPLICATION SITE PRURITUS                                    7               2               2              0             29               3               3              0             24               3               3              0     
      APPLICATION SITE ERYTHEMA                                    3               0               0              0             19               3               3              0             14               2               2              0     
      APPLICATION SITE IRRITATION                                  3               1               1              0             12               1               1              0              9               3               3              0     
      NERVOUS SYSTEM DISORDERS                                                                                                                                                                                                                      
      DIZZINESS                                                    2               0               0              0             15               3               3              0              9               1               1              0     
      GASTROINTESTINAL DISORDERS                                                                                                                                                                                                                    
      DIARRHOEA                                                   10               1               1              0              4               0               0              0              6               2               2              0     
      CARDIAC DISORDERS                                                                                                                                                                                                                             
      SINUS BRADYCARDIA                                            2               0               0              0             11               0               0              0              7               0               0              0     

# AET04_PI variant 8 is produced correctly

    Code
      res
    Output
                                                      Placebo                                Xanomeline High Dose                           Xanomeline Low Dose            
                                    Any Grade (%)   Grade 3-4 (%)   Grade 5 (%)   Any Grade (%)   Grade 3-4 (%)   Grade 5 (%)   Any Grade (%)   Grade 3-4 (%)   Grade 5 (%)
                                       (N=86)          (N=86)         (N=86)         (N=72)          (N=72)         (N=72)         (N=96)          (N=96)         (N=96)   
      —————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
      PRURITUS                            9               3              0             36               8              0             24               1              1     
      APPLICATION SITE PRURITUS           7               2              0             29               3              0             24               3              0     
      ERYTHEMA                           10               0              0             19               0              0             16               2              0     
      APPLICATION SITE ERYTHEMA           3               0              0             19               3              0             14               2              0     
      RASH                                6               1              0             15               1              0             14               2              0     
      DIZZINESS                           2               0              0             15               3              0              9               1              0     
      APPLICATION SITE IRRITATION         3               1              0             12               1              0              9               3              0     
      DIARRHOEA                          10               1              0              4               0              0              6               2              0     
      SINUS BRADYCARDIA                   2               0              0             11               0              0              7               0              0     

